Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 22:e01582.
doi: 10.1002/cbdv.202501582. Online ahead of print.

Amazonian Cyanobacteria as a Source of Bioactive Compounds With Antimicrobial and Cytotoxic Properties

Affiliations

Amazonian Cyanobacteria as a Source of Bioactive Compounds With Antimicrobial and Cytotoxic Properties

Samuel Cavalcante do Amaral et al. Chem Biodivers. .

Abstract

Cyanobacteria are photosynthetic microorganisms known for producing diverse bioactive compounds. This study explores the bioactivity of extracts and fractions from Amazonian cyanobacteria and their pigment and phenolic compound production. A fraction from Synechococcus sp. CACIAM 05 showed cytotoxicity against hCMEC/D3 and MG-63 cells. UPLC-HRMS/MS analysis of this fraction (C5FD) identified pheophytin and phorbide derivatives as key bioactive molecules. In antimicrobial assays, another fraction from the same strain exhibited bactericidal activity against Bacillus subtilis ATCC 6633, with a MIC of 40 µg mL-1. Additional strains also showed antibacterial effects, though with higher MICs. Allelopathic activity identified eleven bioactive strains, including a synergistic effect between Desmonostoc sp. CACIAM 45 and Synechocystis sp. CACIAM 05. Aqueous extracts from Lyngbya sp. CACIAM 07 and Desmonostoc sp. CACIAM 45 showed the highest total phenolic content. Cultivation of Desmonostoc sp. CACIAM 45 in different media indicated CHU-10 and ASM as optimal for phenolic and phycobiliprotein production. These findings contribute to the field by unveiling novel bioactivities and metabolic profiles of Amazonian cyanobacteria, supporting their potential as a valuable source of natural products for pharmaceutical and biotechnological applications.

Keywords: LC–MS‐based metabolomic; OSMAC (One Strain Many Compounds); bioactivity; cyanobacteria; phycobiliproteins.

PubMed Disclaimer

References

    1. P. Sánchez‐Baracaldo, G. Bianchini, J. D. Wilson, and A. H. Knoll, “Cyanobacteria and Biogeochemical Cycles Through Earth History,” Trends in Microbiology 30 (2022): 143–157, 10.1016/j.tim.2021.05.008.
    1. V. Ramos, J. Morais, R. Castelo‐Branco, et al., “Cyanobacterial Diversity Held in Microbial Biological Resource Centers as a Biotechnological Asset: The Case Study of the Newly Established LEGE Culture Collection,” Journal of Applied Phycology 30 (2018): 1437–1451, https://doi.org/10.1007/s10811‐017‐1369‐y.
    1. M. Mutalipassi, G. Riccio, V. Mazzella, et al., “Symbioses of Cyanobacteria in Marine Environments: Ecological Insights and Biotechnological Perspectives,” Marine Drugs 19 (2021): 227, 10.3390/md19040227.
    1. P. N. N. de Freitas, F. R. Jacinavicius, L. S. Passos, A. O. de Souza, R. B. Dextro, and E. Pinto, “Exploring the Biodiversity of Antarctic Cyanobacteria: A Review of Secondary Metabolites and Their Applications,” Algal Research 82 (2024): 103617, 10.1016/j.algal.2024.103617.
    1. Z. Duan, G. Feng, X. Tan, and R. Zhu, “Intra‐Colony Light Regulates Morphology Diversity of Colonial Cyanobacteria,” Algal Research (2025): 85, 10.1016/j.algal.2024.103829.

LinkOut - more resources